Drug Profile
Tolcapone
Alternative Names: RO 407592; TasmarLatest Information Update: 06 Oct 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Antiparkinsonians; Benzophenones; Nitrophenols; Small molecules
- Mechanism of Action Catechol O-methyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Parkinson's disease
Most Recent Events
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 07 Sep 2009 No development reported - Preregistration for Parkinson's disease in Japan (PO)
- 23 Feb 2006 Data presented at the 18th World Congress of Neurology (WCN-2005) have been added to the adverse events section